SHANGHAI MODERN PHARMACEUTICAL CO.,LTD.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Public, Subsidiary
- Established
- 1996-11-27
- Employees
- 559
- Market Cap
- -
- Website
- http://www.shyndec.com
- Introduction
The company was founded in 1996 and is a high-tech enterprise in the pharmaceutical industry specializing in R&D, production and sales of pharmaceutical products, founded by academicians of the Chinese Academy of Engineering. The company was listed on the Shanghai Stock Exchange on June 16, 2004. Joined China Pharmaceutical Group Co., Ltd. in April 2010. The...
Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Early Morning Blood Pressure and Central Arterial Pressure
Phase 4
- Conditions
- Interventions
- First Posted Date
- 2015-02-06
- Last Posted Date
- 2015-02-06
- Lead Sponsor
- Shanghai Shyndec Pharmaceutical Co., Ltd.
- Target Recruit Count
- 244
- Registration Number
- NCT02357615
- Locations
- 🇨🇳
Ruijin Hospital Affiliated to Shanghai Jiao Tong University Medical School, Shanghai, China
Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Mild to Moderate Essential Hypertension
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-01-09
- Last Posted Date
- 2015-02-05
- Lead Sponsor
- Shanghai Shyndec Pharmaceutical Co., Ltd.
- Target Recruit Count
- 38
- Registration Number
- NCT02031861
- Locations
- 🇨🇳
Ruijin Hospital Affiliated to Shanghai Jiao Tong University Medical School, Shanghai, Shanghai, China
© Copyright 2024. All Rights Reserved by MedPath